If it works it would set the stage for rapid adoption in many countries.

I really respect new ideas and innovative thinking that solve problems from new angles possibly saving money or resulting in breakthrough impacts. In the case of RVX and Monocco or Saudi Arabia or the abuse of forward looking statements I don't consider these actions to be creative innovations. They seem bizarre and rooted in desperation.

If it were not for the numerous peer reviewed scientific publications in highly respected journals for both apabetalone and zen3694 I would not touch this company with a 10 foot pole.

That being said my background is in communication and marketing strategy development. Given the significant positive scientific news about apabetalone there are numerous positive and powerful stories to tell the investing public. It would be fairly easy to hire a talented creative team (PR + brand building experts) for relatively low cost (some actual payment plus lots of shares) to create an almost continuous flow of high impact communications to investors that could permeate the globe.

Oh well.

Toinv